339 related articles for article (PubMed ID: 21307288)
1. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
[TBL] [Abstract][Full Text] [Related]
2. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
3. Effector T Cell Resistance to Suppression and STAT3 Signaling during the Development of Human Type 1 Diabetes.
Ihantola EL; Viisanen T; Gazali AM; Näntö-Salonen K; Juutilainen A; Moilanen L; Rintamäki R; Pihlajamäki J; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
J Immunol; 2018 Aug; 201(4):1144-1153. PubMed ID: 30006377
[TBL] [Abstract][Full Text] [Related]
4. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.
Goodman WA; Levine AD; Massari JV; Sugiyama H; McCormick TS; Cooper KD
J Immunol; 2009 Sep; 183(5):3170-6. PubMed ID: 19648274
[TBL] [Abstract][Full Text] [Related]
5. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase inhibitor PPP1R11 modulates resistance of human T cells toward Treg-mediated suppression of cytokine expression.
Joshi RN; Fernandes SJ; Shang MM; Kiani NA; Gomez-Cabrero D; Tegnér J; Schmidt A
J Leukoc Biol; 2019 Aug; 106(2):413-430. PubMed ID: 30882958
[TBL] [Abstract][Full Text] [Related]
8. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
9. Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.
Woods DM; Ramakrishnan R; Laino AS; Berglund A; Walton K; Betts BC; Weber JS
Clin Cancer Res; 2018 Dec; 24(24):6236-6247. PubMed ID: 30131384
[TBL] [Abstract][Full Text] [Related]
10. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
11. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
12. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
13. Multiple Environmental Signaling Pathways Control the Differentiation of RORγt-Expressing Regulatory T Cells.
Hussein H; Denanglaire S; Van Gool F; Azouz A; Ajouaou Y; El-Khatib H; Oldenhove G; Leo O; Andris F
Front Immunol; 2019; 10():3007. PubMed ID: 31998303
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation.
van Maren WW; Nierkens S; Toonen LW; Bolscher JM; Sutmuller RP; Adema GJ
BMC Immunol; 2011 Mar; 12():23. PubMed ID: 21435210
[TBL] [Abstract][Full Text] [Related]
15. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
[TBL] [Abstract][Full Text] [Related]
16. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
17. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells.
Pillemer BB; Qi Z; Melgert B; Oriss TB; Ray P; Ray A
J Immunol; 2009 Jul; 183(1):155-63. PubMed ID: 19535633
[TBL] [Abstract][Full Text] [Related]
18. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance.
Priceman SJ; Kujawski M; Shen S; Cherryholmes GA; Lee H; Zhang C; Kruper L; Mortimer J; Jove R; Riggs AD; Yu H
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13079-84. PubMed ID: 23878227
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells.
Oberg HH; Wesch D; Grüssel S; Rose-John S; Kabelitz D
Int Immunol; 2006 Apr; 18(4):555-63. PubMed ID: 16540526
[TBL] [Abstract][Full Text] [Related]
20. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.
Piconese S; Gri G; Tripodo C; Musio S; Gorzanelli A; Frossi B; Pedotti R; Pucillo CE; Colombo MP
Blood; 2009 Sep; 114(13):2639-48. PubMed ID: 19643985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
